TENAX THERAPEUTICS INC (TENX:NASDAQ)
$2.19 0.07 (3.3019%)
Analysed TENAX THERAPEUTICS INC (TENX:NASDAQ) News Sources
Why Did TENX Stock Crash 89% Today?
10-08-2026
stocktwits.com
Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case
11-08-2026
marketbeat.com
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
22-04-2026
yahoo.com
Companies Like Tenax Therapeutics (NASDAQ:TENX) Are In A Position To Invest In Growth
22-04-2026
yahoo.com
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
04-05-2026
yahoo.com
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
12-05-2026
yahoo.com
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
31-07-2026
yahoo.com
Tenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103
10-08-2026
advfn.com
Tenax Therapeutics’ stock crashes on Phase III trial failure
11-08-2026
clinicaltrialsarena.com
What is the current price of TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The current price of TENAX THERAPEUTICS INC (TENX:NASDAQ) is $2.19.
TENAX THERAPEUTICS INC (TENX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TENAX THERAPEUTICS INC (TENX:NASDAQ) since the previous trading day is $0.07.
TENAX THERAPEUTICS INC (TENX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TENAX THERAPEUTICS INC (TENX:NASDAQ) since the previous trading day is 3.3019%.
What is the most recent average sentiment score for TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The most recent average sentiment score for TENAX THERAPEUTICS INC (TENX:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The most recent sentiment for TENAX THERAPEUTICS INC (TENX:NASDAQ) is .
SEC-8K** Filing Available For TENAX THERAPEUTICS INC (TENX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.